The peptide
Palmitoyl Pentapeptide-4: The Matrikine Signal for Comprehensive ECM Regeneration
Palmitoyl Pentapeptide-4 (Pal-KTTKS) is a highly specific signal peptide, enhanced with a palmitic acid chain for superior stratum corneum penetration. As a matrikine, it expertly mimics a subfragment of type I procollagen, signaling dermal fibroblasts to synthesize essential extracellular matrix components including collagen types I, III, and IV, elastin, fibronectin, and glycosaminoglycans. This non-irritating peptide offers a gold-standard alternative to retinoids, delivering profound wrinkle reduction and enhanced elasticity without compromising the skin’s vital barrier.
Market context: Sederma pioneered the peptide market by introducing the original Palmitoyl Pentapeptide-4 under the trade name Matrixyl, establishing it as a foundational collagen-stimulating active. While their proprietary portfolio later evolved to include Matrixyl 3000—a dual-peptide blend excluding Palmitoyl Pentapeptide-4—Formulate Labs exclusively supplies the unbranded, high-purity Palmitoyl Pentapeptide-4 INCI active. We do not sell or represent supplier-branded SKUs, enabling independent manufacturers to achieve identical clinical efficacy without trade-name markups.
Formulate Labs provides Palmitoyl Pentapeptide-4 as a 0.1% standard suspension, conveniently pre-dispersed in our Glycerin/Water or Sea Kelp Bioferment stock carriers. This ready-to-use format simplifies integration into your cosmetic formulations, ensuring optimal peptide integrity. When formulating with 3.0% to 8.0% of our 0.1% suspension, you achieve the clinically proven 3 to 5 ppm final active concentration.
We supply it at 0.05% standard (Matrixyl reference) or 0.5% lab concentrate in glycerin or Sea Kelp Bioferment carriers.
578
g/mol molecular weight (approx.)
2000
first published by Sederma (Matrixyl™)
2
carrier options on this page